Upper Extremity Clinical Trials
2 recruiting trials for Upper Extremity. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Upper Extremity clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Seoul National University Hospital (1), Ankara Yildirim Beyazıt University (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Shoulder orthosis (device, 1 trial).
Track Upper Extremity trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
The Effect of a Muscle-mimicking, Fabric-type Shoulder Orthosis on Functional Movements of the Upper Limb in Patients...
The goal of this clinical trial is to investigate the effect of a muscle-mimicking, fabric-type shoulder orthosis on functional movements of the upper limb in patients with...
Scapular Muscle Activation and Shoulder Performance in Migraine
Migraine is a significant health problem due to its high prevalence and substantial contribution to disability. Individuals with migraine have been reported to exhibit myofascial...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Upper Extremity, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Upper Extremity, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Upper Extremity, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.